Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

NCT07109219 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia (B-ALL)

Interventions

COMBINATION_PRODUCT: AZD4512 monotherapy

Sponsor

AstraZeneca

Collaborators

[object Object]